NASDAQ: ANL
Adlai Nortye Ltd Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their ANL stock forecasts and price targets.

Forecast return on equity

Is ANL forecast to generate an efficient return?

Company
-469.13%
Industry
27.48%
Market
56.42%
ANL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ANL forecast to generate an efficient return on assets?

Company
-167.75%
Industry
10.8%
ANL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ANL earnings per share forecast

What is ANL's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$1.08
Avg 2 year Forecast
-$1.08

ANL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANL$1.50N/AN/A
VRCA$0.60N/AN/A
PDSB$1.22$13.00+965.57%Buy
PMVP$1.05$5.00+376.19%Buy
IRD$0.94$6.33+573.72%Strong Buy

Adlai Nortye Stock Forecast FAQ

What is ANL's earnings growth forecast for 2025-2026?

(NASDAQ: ANL) Adlai Nortye's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 23.95%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 58%.

Adlai Nortye's earnings in 2025 is -$51,869,000.On average, 1 Wall Street analyst forecast ANL's earnings for 2025 to be -$119,556,867, with the lowest ANL earnings forecast at -$119,556,867, and the highest ANL earnings forecast at -$119,556,867.

In 2026, ANL is forecast to generate -$119,556,867 in earnings, with the lowest earnings forecast at -$119,556,867 and the highest earnings forecast at -$119,556,867.

If you're new to stock investing, here's how to buy Adlai Nortye stock.

What is ANL's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: ANL) forecast ROE is -469.13%, which is considered weak.

What is ANL's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: ANL) Adlai Nortye's current Earnings Per Share (EPS) is -$1.62. On average, analysts forecast that ANL's EPS will be -$1.08 for 2025, with the lowest EPS forecast at -$1.08, and the highest EPS forecast at -$1.08. In 2026, ANL's EPS is forecast to hit -$1.08 (min: -$1.08, max: -$1.08).

What is ANL's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: ANL) forecast ROA is -167.75%, which is lower than the forecast US Biotechnology industry average of 10.8%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.